microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis
出版年份 2020 全文链接
标题
microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 39, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-09-24
DOI
10.1186/s13046-020-01670-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- IL-6 and IL-8 are involved in JMJD2A-regulated malignancy of ovarian cancer cells
- (2020) Haiyu Zhang et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- HIF1α‐dependent metabolic reprogramming governs mesenchymal stem/stromal cell immunoregulatory functions
- (2020) Rafael Contreras‐Lopez et al. FASEB JOURNAL
- Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin
- (2019) Chao He et al. Clinical Epigenetics
- The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis
- (2019) Liangfeng Chen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cytotoxic effects and apoptosis induction of cisplatin-loaded iron oxide nanoparticles modified with chitosan in human breast cancer cells
- (2019) Ali Morovati et al. MOLECULAR BIOLOGY REPORTS
- Combination Treatment With Sorafenib and Everolimus Regresses a Doxorubicin-resistant Osteosarcoma in a PDOX Mouse Model
- (2019) TAKASHI HIGUCHI et al. ANTICANCER RESEARCH
- Oral Recombinant Methioninase, Combined With Oral Caffeine and Injected Cisplatinum, Overcome Cisplatinum-Resistance and Regresses Patient-derived Orthotopic Xenograft Model of Osteosarcoma
- (2019) TAKASHI HIGUCHI et al. ANTICANCER RESEARCH
- The Notch Pathway Promotes Osteosarcoma Progression through Activation of Ephrin Reverse Signaling
- (2019) Ling Yu et al. MOLECULAR CANCER RESEARCH
- JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing β-catenin signaling pathway
- (2019) Xinnan Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Marital Status and Survival in Osteosarcoma Patients: An Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database
- (2019) Shui Qiu et al. MEDICAL SCIENCE MONITOR
- Prognostic factors for survival among patients with primary bone sarcomas of small bones
- (2018) Zhan Wang et al. Cancer Management and Research
- MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1
- (2018) Wei Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?
- (2017) Gaia Palmini et al. MOLECULES
- Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma
- (2017) Kuisheng Liu et al. Cell Death & Disease
- lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy
- (2017) Xiang Zhou et al. Cell Death & Disease
- Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun
- (2017) Gang Huang et al. Oncotarget
- HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins
- (2017) Lei Sun et al. Journal of Cancer
- SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer
- (2016) Z Zhou et al. ONCOGENE
- Histone demethylase JMJD2B and JMJD2C induce fibroblast growth factor 2: mediated tumorigenesis of osteosarcoma
- (2015) Xiaojiang Li et al. MEDICAL ONCOLOGY
- Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal
- (2015) Suoyuan Li et al. TUMOR BIOLOGY
- microRNAs as Developmental Regulators
- (2015) Kathryn N. Ivey et al. Cold Spring Harbor Perspectives in Biology
- MicroRNA-24 Regulates Macrophage Behavior and Retards Atherosclerosis
- (2014) Karina Di Gregoli et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy
- (2014) Juntao Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)
- (2014) Y Kurokawa et al. BRITISH JOURNAL OF CANCER
- TRAF4 Enhances Osteosarcoma Cell Proliferation and Invasion by Akt Signaling Pathway
- (2014) Weitao Yao et al. ONCOLOGY RESEARCH
- HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors
- (2013) Deanna D Dailey et al. BMC Veterinary Research
- starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data
- (2013) Jun-Hao Li et al. NUCLEIC ACIDS RESEARCH
- miRNA expression profile in human osteosarcoma: Role of miR-1 and miR-133b in proliferation and cell cycle control
- (2012) CHIARA NOVELLO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- G9a Histone Methyltransferase Activity in Retinal Progenitors Is Essential for Proper Differentiation and Survival of Mouse Retinal Cells
- (2012) K. Katoh et al. JOURNAL OF NEUROSCIENCE
- Expression and stability of hypoxia inducible factor 1α in osteosarcoma
- (2012) Amal El Naggar et al. PEDIATRIC BLOOD & CANCER
- Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
- (2012) W. Luo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HMGB1 Promotes Drug Resistance in Osteosarcoma
- (2011) J. Huang et al. CANCER RESEARCH
- Analysis of rpoS and bolA gene expression under various stress-induced environments in planktonic and biofilm phase using 2−ΔΔCT method
- (2011) Mohd Adnan et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Osteosarcoma incidence and survival rates from 1973 to 2004
- (2009) Lisa Mirabello et al. CANCER
- Therapy for Osteosarcoma
- (2008) Alexander J Chou et al. PEDIATRIC DRUGS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started